Literature DB >> 30370147

Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer.

Lorraine D Cornwell1, Drew Moghanaki2.   

Abstract

Entities:  

Year:  2018        PMID： 30370147      PMCID： PMC6186645          DOI： 10.21037/jtd.2018.08.83

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.

Authors:  Masatsugu Hamaji; Fengshi Chen; Yukinori Matsuo; Atsushi Kawaguchi; Satoshi Morita; Nami Ueki; Makoto Sonobe; Yasushi Nagata; Masahiro Hiraoka; Hiroshi Date
Journal:  Ann Thorac Surg       Date:  2015-02-07       Impact factor: 4.330

2.  Surgery vs. SBRT in retrospective analyses: confounding by operability is the elephant in the room.

Authors:  William A Stokes; Chad G Rusthoven
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Minimally invasive surgery is best treatment for early lung cancer.

Authors:  Scott J Swanson
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

5.  Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

Authors:  Gregory M M Videtic; Jessica Donington; Meredith Giuliani; John Heinzerling; Tomer Z Karas; Chris R Kelsey; Brian E Lally; Karen Latzka; Simon S Lo; Drew Moghanaki; Benjamin Movsas; Andreas Rimner; Michael Roach; George Rodrigues; Shervin M Shirvani; Charles B Simone; Robert Timmerman; Megan E Daly
Journal:  Pract Radiat Oncol       Date:  2017-06-05

6.  A survey of stereotactic body radiotherapy use in the United States.

Authors:  Hubert Pan; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Cancer       Date:  2011-03-15       Impact factor: 6.860

7.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

8.  Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis.

Authors:  Waqar Haque; Sean Szeja; Anne Tann; Sarathi Kalra; Bin S Teh
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339

9.  Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Naoko Sanuki; Yuichiro Tsurugai; Yousuke Aoki; Yohei Oku; Yu Hara; Takeshi Akiba; Naoyuki Shigematsu
Journal:  Lung Cancer       Date:  2017-05-04       Impact factor: 5.705

10.  Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

Authors:  Yasushi Nagata; Masahiro Hiraoka; Taro Shibata; Hiroshi Onishi; Masaki Kokubo; Katsuyuki Karasawa; Yoshiyuki Shioyama; Rikiya Onimaru; Takuyo Kozuka; Etsuo Kunieda; Tsutomu Saito; Keiichi Nakagawa; Masato Hareyama; Yoshihiro Takai; Kazushige Hayakawa; Norio Mitsuhashi; Satoshi Ishikura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-11       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.